Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2012-12-21

FDA Approved: JUXTAPID — Original Application (Amryt Pharmaceuticals DAC)

View source ↗

Summary

FDA approved Juxtapid (lomitapide) via an original application for homozygous familial hypercholesterolemia to reduce LDL cholesterol in affected adults, markin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • JUXTAPID (lomitapide)

Snippet

ORIG AP for JUXTAPID (LOMITAPIDE MESYLATE)